¼¼°èÀÇ Ãø¹æÀ¯µ¿ ¾î¼¼ÀÌ ½ÃÀå
Lateral Flow Assays
»óǰÄÚµå : 1650677
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 461 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,263,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,789,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Ãø¹æÀ¯µ¿ ¾î¼¼ÀÌ ¼¼°è ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 147¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 108¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â Ãø¹æÀ¯µ¿ ¾î¼¼ÀÌ ¼¼°è ½ÃÀåÀº 2024-2030³â µ¿¾È ¿¬Æò±Õ 5.3%ÀÇ CAGR·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 147¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀΠŰƮ ¹× ½Ã¾àÀº CAGR 5.4%¸¦ ±â·ÏÇÏ¿© ºÐ¼® ±â°£ Á¾·á ½ÃÁ¡¿¡ 123¾ï ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Ãø¸é È帧 ÆÇµ¶±â ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 4.4%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº ¾à 40¾ï ´Þ·¯, Áß±¹Àº CAGR 7.7%·Î ¼ºÀå Àü¸Á

¹Ì±¹ÀÇ Ãø¹æÀ¯µ¿ ¾î¼¼ÀÌ ½ÃÀå ±Ô¸ð´Â 2024³â 40¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 12¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2024-2030³â ºÐ¼® ±â°£ µ¿¾È 7.7%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ª ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ µ¿¾È °¢°¢ 3.2% ¹× 4.9%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.2%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è Ãø¹æÀ¯µ¿ ¾î¼¼ÀÌ ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ Á¤¸®

Ãø¹æÀ¯µ¿ ¾î¼¼ÀÌ(LFA)´Â ÀÇ·á Áø´Ü, ½Äǰ ¾ÈÀü, ȯ°æ °Ë»ç µî ´Ù¾çÇÑ ºÐ¾ß¿¡¼­ ³Î¸® »ç¿ëµÇ´Â Áø´Ü µµ±¸·Î, LFA´Â °£´ÜÇϰí È¿°úÀûÀÎ ¿ø¸®·Î ÀÛµ¿Çϸç, ½Ã·á¸¦ Å×½ºÆ® ½ºÆ®¸³¿¡ Àû¿ëÇÏ¿© ½ºÆ®¸³¿¡ °¡½Ã¼±À» Ç¥½ÃÇÕ´Ï´Ù. LFA´Â ºü¸¥ °á°ú, »ç¿ë ÆíÀǼº, ºñ¿ë È¿À²¼ºÀ¸·Î À¯¸íÇϸç, ½Å¼ÓÇÑ ÀÇ»ç°áÁ¤ÀÌ Áß¿äÇÑ »óȲ¿¡¼­ ƯÈ÷ À¯¿ëÇÏ°Ô »ç¿ëµÇ¸ç, LFAÀÇ °¡Àå Ä£¼÷ÇÑ ¿¹´Â °¡Á¤¿ë ÀӽŠÅ×½ºÆ®±âÀÔ´Ï´Ù. ÀӽŠ°Ë»ç»Ó¸¸ ¾Æ´Ï¶ó LFA´Â °¨¿°¼º ÁúȯÀÇ °ËÃâ, ¸¸¼ºÁúȯÀÇ ¸ð´ÏÅ͸µ, ½Äǰ ¹× ¹°ÀÇ ¾ÈÀü¼º È®º¸ µî¿¡µµ Ȱ¿ëµÇ°í ÀÖ¾î ±× ¹ü¿ë¼º°ú Àû¿ë ¹üÀ§°¡ ¸Å¿ì ³Ð½À´Ï´Ù.

ÃÖ±Ù ¸î ³â µ¿¾È LFAÀÇ Á߿伺ÀÌ ±ÞÁõÇϰí ÀÖÀ¸¸ç, ´ë±Ô¸ð °Ë»ç¿¡¼­ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. °í±Þ ½ÇÇè Àåºñ ¾øÀ̵µ ½Å¼ÓÇÏ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â °á°ú¸¦ Á¦°øÇÏ´Â LFAÀÇ ´É·ÂÀº Àü¿°º´ °ü¸®¿¡ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® Àâ¾ÒÀ¸¸ç, LFA´Â Ç׿ø ¹× Ç×ü¸¦ Æ÷ÇÔÇÑ ´Ù¾çÇÑ ¹ÙÀÌ¿À¸¶Ä¿ÀÇ °ËÃâ¿¡µµ Àû¿ëµÇ¾î ±¤¹üÀ§ÇÏ°í ½±°Ô ÀÌ¿ëÇÒ ¼ö ÀÖ´Â °Ë»ç¸¦ °¡´ÉÇÏ°Ô Çß½À´Ï´Ù. ¶ÇÇÑ, LFA ±â¼úÀÇ Áö¼ÓÀûÀÎ ¹ßÀüÀ¸·Î ¹Î°¨µµ¿Í ƯÀ̵µ°¡ Çâ»óµÇ¾î Àú³óµµÀÇ ºÐ¼®¹° °ËÃâÀÌ °¡´ÉÇØÁ³°í, À§¾ç¼º ¹× À§À½¼ºÀÇ °¡´É¼ºÀÌ °¨¼ÒÇß½À´Ï´Ù. ÀÌ·¯ÇÑ °³¼±À¸·Î LFAÀÇ Àû¿ë ¹üÀ§°¡ È®´ëµÇ¾î ´õ ³ÐÀº Áø´Ü ÀÀ¿ë ºÐ¾ß¿¡ ÀûÇÕÇÏ°Ô µÇ¾úÀ¸¸ç, LFAÀÇ ¹ßÀüÀº ¶ÇÇÑ ¼±Åüº, ¹Î°¨µµ ¹× Á¤·®¼ºÀ» Çâ»ó½Ã۱â À§ÇÑ °ÍÀÔ´Ï´Ù. ½Ã·áÀÇ °Ë»ç ¶óÀÎÀÇ °­µµ¸¦ ÃøÁ¤Çϱâ À§ÇØ ´Ù¾çÇÑ È¸»ç¿¡¼­ Å×½ºÆ® ¸®´õ¸¦ Á¦°øÇϰí ÀÖÁö¸¸, È޴뼺ÀÌ ¶Ù¾î³ª°í ¼ÒÇüÈ­µÈ ÀåÄ¡°¡ ÈÞ´ë¿ë Ãø¹æÀ¯µ¿ ¾î¼¼ÀÌ ¸®´õÀÇ º¸±ÞÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, CCD ¹× CMOS °ËÃâ ±â¼ú°ú °°Àº ´Ù¾çÇÑ ½Ã·á °ËÃâ ¹æ¹ýÀÇ µµÀÔ°ú ÇÔ²² ½Ã·á¸¦ ºñÃß´Â µ¶Æ¯ÇÑ ÆÄÀåÀÇ »ç¿ë Áõ°¡µµ ±â¼ú Çõ½ÅÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. °Ë»ç¿¡ ƯȭµÈ °í±Þ À̹ÌÁö ó¸® ¾Ë°í¸®ÁòÀ» »ç¿ëÇÒ ¼ö ÀÖ°Ô µÊ¿¡ µû¶ó ½Ã·á ºÐ¼®¹°ÀÇ Á¤·®¼ºÀÌ Çâ»óµÇ¾ú½À´Ï´Ù.

Ãø¹æÀ¯µ¿ ¾î¼¼ÀÌ ½ÃÀåÀÇ ¼ºÀåÀº ±â¼ú ¹ßÀü, POC(Point-of-Care) °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ¼ÒºñÀÚ ÇൿÀÇ ÁøÈ­ µî ¿©·¯ ¿äÀÎÀ¸·Î ÀÎÇØ ¹ß»ýÇÕ´Ï´Ù. ½º¸¶Æ®Æù ±â¹Ý ¸®´õ±â ¹× µðÁöÅÐ Ç÷§Æû ÅëÇÕ°ú °°Àº ±â¼ú Çõ½ÅÀ¸·Î ÀÎÇØ LFAÀÇ ±â´É°ú »ç¿ëÀÚ °æÇèÀÌ Å©°Ô Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº ´õ ³ªÀº µ¥ÀÌÅÍ °ü¸®, ¿ø°Ý ¸ð´ÏÅ͸µ, ÀÇ·á ¼­ºñ½º Á¦°øÀÚ¿ÍÀÇ ½Ç½Ã°£ °á°ú °øÀ¯¸¦ °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ¸¸¼ºÁúȯ°ú °¨¿°¼º ÁúȯÀÇ È®»êÀº ÀüÅëÀûÀÎ ÀÇ·á ȯ°æ ¹Û¿¡¼­ »ç¿ëÇÒ ¼ö ÀÖ´Â ºü¸£°í ½Å·ÚÇÒ ¼ö ÀÖ´Â Áø´Ü µµ±¸¿¡ ´ëÇÑ ¼ö¿ä¸¦ °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. ¼ÒºñÀÚ ÇൿÀÌ º¸´Ù Àû±ØÀûÀÎ °Ç°­ °ü¸®·Î ÀüȯµÇ°í ÀÖÀ¸¸ç, °³ÀÎÀº Æí¸®ÇÏ°í ½±°Ô ÀÌ¿ëÇÒ ¼ö ÀÖ´Â °Ë»ç ¿É¼ÇÀ» ¿øÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±ÔÁ¦ ´ç±¹ÀÇ Áö¿ø°ú Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê¸¦ ÅëÇØ ÇöÀå Áø´Ü µµ±¸ÀÇ °³¹ß ¹× äÅÃÀ» ÃËÁøÇÏ´Â Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºêµµ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. Áø´Ü ±â¾÷µé°ú ¿¬±¸±â°üµéÀÇ Çù¾÷Àº Çõ½ÅÀ» ÃËÁøÇϰí, ¼º´É Çâ»ó°ú ±â´É È®ÀåÀ» ÅëÇØ Â÷¼¼´ë LFA¸¦ °³¹ßÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ º¹ÇÕÀûÀ¸·Î ÀÛ¿ëÇÏ¿© LFA ½ÃÀåÀÇ °ß°íÇÑ ¼ºÀå°ú Áö¼ÓÀûÀÎ ÁøÈ­¸¦ º¸ÀåÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç°(ŰƮ ¹× ½Ã¾à, Ãø¸é È帧 ÆÇµ¶±â), ¿ëµµ(ÀÓ»ó °Ë»ç, µ¿¹° Áø´Ü, ±âŸ ¿ëµµ), ÃÖÁ¾ ¿ëµµ(º´¿ø ¹× Ŭ¸®´Ð, Áø´Ü ¿¬±¸¼Ò, Á¦¾à ¹× »ý¸í°øÇÐ ±â¾÷, ±âŸ ÃÖÁ¾ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê(ÃÑ 55°Ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Lateral Flow Assays Market to Reach US$14.7 Billion by 2030

The global market for Lateral Flow Assays estimated at US$10.8 Billion in the year 2024, is expected to reach US$14.7 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Kits & Reagents, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$12.3 Billion by the end of the analysis period. Growth in the Lateral Flow Readers segment is estimated at 4.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.0 Billion While China is Forecast to Grow at 7.7% CAGR

The Lateral Flow Assays market in the U.S. is estimated at US$4.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 7.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 4.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Lateral Flow Assays Market - Key Trends & Drivers Summarized

Lateral Flow Assays (LFAs) are a widely utilized diagnostic tool in various fields, including medical diagnostics, food safety, and environmental testing. These assays operate on a simple yet effective principle: a sample is applied to a test strip, and the presence of a target analyte is indicated by a visible line on the strip. LFAs are renowned for their rapid results, ease of use, and cost-effectiveness, making them particularly valuable in settings where quick decision-making is crucial. One of the most familiar examples of LFAs is the home pregnancy test. Beyond pregnancy tests, LFAs are employed for detecting infectious diseases, monitoring chronic conditions, and ensuring food and water safety, highlighting their versatility and broad applicability.

In recent years, the significance of LFAs has surged where they played a pivotal role in large-scale testing efforts. The ability of LFAs to provide quick and reliable results without the need for sophisticated laboratory equipment made them indispensable in managing the pandemic. Their application extended to detecting various biomarkers, including antigens and antibodies, facilitating widespread and accessible testing. Furthermore, ongoing advancements in LFA technology have enhanced their sensitivity and specificity, enabling the detection of lower concentrations of analytes and reducing the likelihood of false positives and negatives. These improvements have expanded the scope of LFAs, making them suitable for a broader range of diagnostic applications. Advancements in LFAs are also intended to improve these assays on the basis of selectivity, sensitivity and quantification. While test readers offered by various players are finding increasing acceptance to measure intensity of test line of specimen, devices with high level of portability and miniaturization are boosting uptake of handheld lateral flow assay readers. Innovations are also favored by increasing use of unique wavelengths to illuminate samples along with implementation of different sample detection methods like CCD or CMOS detection technology. The availability of advanced test-specific image processing algorithms has improved sample analyte quantification.

The growth in the Lateral Flow Assays market is driven by several factors, including technological advancements, increasing demand for point-of-care testing, and evolving consumer behavior. Technological innovations, such as the integration of smartphone-based readers and digital platforms, have significantly enhanced the functionality and user experience of LFAs. These advancements enable better data management, remote monitoring, and real-time result sharing with healthcare providers. The rising prevalence of chronic and infectious diseases has also spurred demand for rapid and reliable diagnostic tools that can be used outside traditional healthcare settings. Consumer behavior is shifting towards more proactive health management, with individuals seeking convenient and accessible testing options. Additionally, regulatory support and government initiatives promoting the development and adoption of point-of-care diagnostics are accelerating market growth. Collaborations between diagnostic companies and research institutions are fostering innovation, leading to the development of next-generation LFAs with improved performance and expanded capabilities. These factors collectively ensure the robust growth and ongoing evolution of the LFA market.

SCOPE OF STUDY:

The report analyzes the Lateral Flow Assays market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Kits & Reagents, Lateral Flow Readers); Application (Clinical Testing, Veterinary Diagnostics, Other Applications); End-Use (Hospitals & Clinics, Diagnostic Laboratories, Pharma & Biotech Companies, Other End-Uses)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 55 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â